| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,101 | 8,142 | 14,163 | 8,049 | | Cost of Revenue | 2,427 | 1,439 | 1,834 | 1,193 | | | Gross Profit | 4,674 | 6,703 | 12,329 | 6,856 | | | Operating Expenses | | Research Development | 5,489 | 6,391 | 5,654 | 7,594 | | Selling General and Administrative | 6,997 | 9,192 | 6,351 | 6,214 | | Non Recurring |
-
|
-
|
-
| 4,700 | | Others | 950 | 950 | 950 | 158 | | | | Total Operating Expenses |
-
|
-
|
-
| 18,666 | | | | Operating Income or Loss | (8,762) | (9,830) | (626) | (11,810) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 372 | 125 | 104 | 609 | | Earnings Before Interest And Taxes | (9,536) | (9,705) | 624 | (11,201) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (9,536) | (9,705) | 624 | (11,201) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
| 1,146 | 2,538 | | | | Net Income From Continuing Ops | (8,390) | (9,705) | 624 | (8,663) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,390) | (9,705) | 624 | (8,663) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,390) | ($9,705) | $624 | ($8,663) |
|
0.26% Nasdaq 
0.01 (0.22%) 
Income Statement
